Madison, Wis. – A technology that could enhance the ability to monitor the spread of diseases such as avian influenza, and also be useful in vaccine development, has received a funding boost.
Platypus Technologies, LLC, will receive a Phase II Small Business Innovation Research (SBIR) grant of $1.65 million from the National Institute for Allergy & Infectious Diseases. The grant will be used to continue development of the company’s proprietary liquid crystal based technology to enable rapid detection of antibodies to infectious agents.
Thus far, Platypus Technologies has received more than $11.5 million in SBIR funding to develop products for the physical and life sciences. The company, located in the Fitchburg Technology Campus, has 19 employees.